Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ceri M. Wiggins
Observed names:
C. Wiggins,
Ceri M Wiggins,
Ceri Wiggins
Institutions:
AstraZeneca (United Kingdom),
Horizon Discovery (United Kingdom)
Observed institutions:
AstraZeneca (United Kingdom),
Babraham Institute,
Horizon Discovery (United Kingdom),
Cancer Research UK Scotland Institute
OpenAlex ID:
A5024014884
ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL
2007
·
Katherine E Ewings
, Kathryn Hadfield‐Moorhouse
, et al.
·
The EMBO Journal
·
180
PDF
Bim and the Pro-Survival Bcl-2 Proteins: Opposites Attract, ERK Repels
2007
·
Katherine E. Ewings
, Ceri M. Wiggins
, et al.
·
Cell Cycle
·
159
PDF
Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene‐targeted therapeutics
2009
·
Annette S. Gillings
, Kathryn Balmanno
, et al.
·
FEBS Journal
·
98
BIMEL, an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation
2011
·
Ceri M. Wiggins
, Peter Tsvetkov
, et al.
·
Journal of Cell Science
·
71
c-Cbl is not required for ERK1/2-dependent degradation of BimEL
2007
·
Ceri M. Wiggins
, Hamid Band
, et al.
·
Cellular Signalling
·
26
Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System
2021
·
Juan Carlos Collantes
, Victor M. Tan
, et al.
·
The CRISPR Journal
·
18
Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent
2016
·
Emma J. Haagensen
, Huw D. Thomas
, et al.
·
European Journal of Cancer
·
17
An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation
2024
·
Immacolata Porreca
, Robert Blassberg
, et al.
·
Molecular Therapy
·
16
PDF
A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds
2017
·
Claire J. Cairney
, Lauren S. Godwin
, et al.
·
PLoS Genetics
·
13
PDF
Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM
2010
·
Ceri M. Wiggins
, Mark Johnson
, et al.
·
Cellular Signalling
·
10
Abstract 4289: 3-Dimensional growth reveals KRAS dependency.
2013
·
Rebecca Foster
, Clare Mudd
, et al.
·
Cancer Research
·
3
Hit screening with multivariate robust outlier detection
2024
·
Hui Sun Leong
, Tianhui Zhang
, et al.
·
PLoS ONE
·
2
PDF
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells
2023
·
Anna Dickson
, Niamh Mullooly
, et al.
·
SLAS DISCOVERY
·
2
PDF
Abstract 700: Investigating KRAS synthetic lethal/co-dependency interactions using siRNA and CRISPR
2015
·
Simon F. Scrace
, Elpida Tsonou
, et al.
·
Cancer Research
·
1
CRISPR screening in primary human lung fibroblasts and small airway epithelial cells identifies novel targets to reduce cellular senescence with potential to treat both COPD and IPF
2023
·
Johan Mattsson
, Jenna Bradley
, et al.
·
European Respiratory Journal
Identification of negative regulators of Wnt/β-catenin signaling in lung epithelial cells through whole genome CRISPR screen
2023
·
Markus Tammia
, Anna Dickson
, et al.
·
European Respiratory Journal
Abstract 1927: High-throughput cell line panel drug screening in organoids and 3D systems
2019
·
Tim M. Scales
, Anett Rada-Kovacs
, et al.
·
Tumor Biology
Abstract 1927: High-throughput cell line panel drug screening in organoids and 3D systems
2019
·
Tim M. Scales
, Anett Rada-Kovacs
, et al.
·
Cancer Research
Abstract 2912: CRISPR-Cas9: A tool for rapid target discovery and validation
2018
·
Ceri M. Wiggins
, David Walter
, et al.
·
Cancer Research
Abstract A25: Synthetic lethal CRISPR-Cas9 screen imply an oncogenic role for FBXW7 mutations in colon cancer
2017
·
Jonathan D. Moore
, Chantelle Hudson
, et al.
·
Molecular Cancer Therapeutics
Identifying synthetic lethal targets in colon cancer using CRISPR-Cas9 and siRNA screens
2016
·
P. Russell
, D. Walter
, et al.
·
European Journal of Cancer
Pre-clinical use of isogenic cell lines and tumours in vitro and in vivo for predictive biomarker discovery; impact of KRAS and PI3KCA mutation status on MEK inhibitor activity is model dependent
2016
·
Emma Haagensen
, Huw Thomas
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
The In(del)s and Outs of CRISPR-Cas9 Screens
2016
·
Ceri Wiggins
, Steffen Lawo
·
Genetic Engineering & Biotechnology News
Abstract 2137: Using Rac1 isogenic cells to model tumor metastasis
2012
·
Ceri Wiggins
, Holly Astley
, et al.
·
Cancer Research
Show more works
View as search
Works count:
24
Citation count:
616
H-index:
10
I10-index:
10
Year
Topic
Type